Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
58 participants
OBSERVATIONAL
2019-07-17
2022-12-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be recruited during their ophthalmologic consultation at the Rothschild Foundation, an OCT-A will be realized and data relating to medical history, oral contraceptive intake and nicotine consumption via cigarette or e-cigarette data will be collected.
The objective is to seek an association between retinal vascular density and inhaled nicotine intake.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Smoking on Retinal Vessel Morphology and Functionality
NCT07261176
Dual Wavelength OCT
NCT03843840
OCTA (Optical Coherence Angiography Tomography) Versus Structural OCT(Optical Coherence Tomography) in Neovascular AMD (Age Macular Degeneration)
NCT03939195
Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases
NCT01546181
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
NCT04505618
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
smokers
OCT-A (Optical Coherence Tomography)
Included patients will have an OCT-A and will be questioned about their nicotine intake, their background and taking an oral conception
vapers
OCT-A (Optical Coherence Tomography)
Included patients will have an OCT-A and will be questioned about their nicotine intake, their background and taking an oral conception
non smokers/non vapers
OCT-A (Optical Coherence Tomography)
Included patients will have an OCT-A and will be questioned about their nicotine intake, their background and taking an oral conception
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OCT-A (Optical Coherence Tomography)
Included patients will have an OCT-A and will be questioned about their nicotine intake, their background and taking an oral conception
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For group of vapers : Patient using exclusively the electronic cigarette with a nicotine level of more than 6mg/ml for at least 3 months and at least 1 times per day on average over a week.
* For group of no-smokers no-vapersNon-smoking and no vaping, for more than 6 months
* Caffeine intake within 2 hours prior to the OCT-A exam
* ametropia greater than + 3 dioptres of hyperopia or-3 dioptres of myopia
* astigmatism greater than 2 dioptres
* Known retinal or retina vascular pathology
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation A de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VVR_2019_5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.